These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 69073)

  • 1. Selection of bone-marrow aplasia patients for allogeneic bone-marrow transplantation.
    Mathé G; Schwarzenberg L
    Lancet; 1977 Jun; 1(8026):1361. PubMed ID: 69073
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of syngeneic bone-marrow graft without preconditioning in post-hepatitis marrow aplasia.
    Lancet; 1977 Oct; 2(8041):742-4. PubMed ID: 71545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of the accretion of transplanted allogeneic myelokaryocytes].
    Korenevskaia MI; Bogoiavlenskaia MP; Poreshina LP; Manishkina RP; Orlov GP
    Probl Gematol Pereliv Krovi; 1976 May; 21(5):24-9. PubMed ID: 799302
    [No Abstract]   [Full Text] [Related]  

  • 4. Aplastic anemia (AA) treated by allogeneic marrow transplantation: the Seattle experience.
    Storb R; Weiden PL; Prentice R; Buckner CD; Clift RA; Einstein AB; Fefer A; Johnson FL; Lerner KG; Neiman PE; Sanders JE; Thomas ED
    Transplant Proc; 1977 Mar; 9(1):181-5. PubMed ID: 17191
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone-marrow transplantation (first of two parts).
    Thomas E; Storb R; Clift RA; Fefer A; Johnson FL; Neiman PE; Lerner KG; Glucksberg H; Buckner CD
    N Engl J Med; 1975 Apr; 292(16):832-43. PubMed ID: 234595
    [No Abstract]   [Full Text] [Related]  

  • 6. Antilymphocyte globulin treatment in severe aplastic anemia--comparison with bone marrow transplantation. Report of 60 cases.
    Gluckman E; Devergie A; Faille A; Bussel A; Benbunan M; Bernard J
    Haematol Blood Transfus; 1979; 24():171-9. PubMed ID: 396173
    [No Abstract]   [Full Text] [Related]  

  • 7. Marrow transplantation for severe aplastic anemia: the Seattle experience.
    Storb R; Thomas ED; Appelbaum FR; Clift RA; Deeg HJ; Doney K; Hansen JA; Prentice RL; Sanders JE; Singer JW
    Prog Clin Biol Res; 1984; 148():297-313. PubMed ID: 6379667
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of leukemia and aplastic anemia with histocompatible allogeneic bone marrow transplantation. A review.
    Graw RG; Herzig GP
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1573-81. PubMed ID: 4405057
    [No Abstract]   [Full Text] [Related]  

  • 9. Marrow transplantation in aplastic anemia.
    Storb R; Buckner CD; Fefer A; Clift RA; Neiman PE; Gluksberg H; Lerner KG; Thomas ED
    Transplant Proc; 1974 Dec; 6(4):355-8. PubMed ID: 4612891
    [No Abstract]   [Full Text] [Related]  

  • 10. Allogeneic marrow grafting for treatment of aplastic anemia.
    Storb R; Thomas ED; Buckner CD; Clift RA; Johnson FL; Fefer A; Glucksberg H; Giblett ER; Lerner KG; Neiman P
    Blood; 1974 Feb; 43(2):157-80. PubMed ID: 4149232
    [No Abstract]   [Full Text] [Related]  

  • 11. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of bone marrow aplasia by bone marrow graft after conditioning with antilymphocyte globulin. Long term results.
    Mathé G; Schwarzenberg L
    Exp Hematol; 1976 Jul; 4(4):256-64. PubMed ID: 782897
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.
    Arai Y; Kondo T; Yamazaki H; Takenaka K; Sugita J; Kobayashi T; Ozawa Y; Uchida N; Iwato K; Kobayashi N; Takahashi Y; Ishiyama K; Fukuda T; Ichinohe T; Atsuta Y; Mori T; Teshima T;
    Haematologica; 2016 May; 101(5):644-52. PubMed ID: 26858357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of high-risk patients with aplastic anaemia in selection for allogeneic 0one-marrow transplantation.
    Lohrmann HP; Kern P; Niethammer D; Heimpel H
    Lancet; 1976 Sep; 2(7987):647-50. PubMed ID: 60514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone marrow biopsy investigation: an important prognostic factor in aplastic anaemia (author's transl)].
    Meusers P; Burkhardt R; König E; Brittinger G
    Med Klin; 1977 Jun; 72(23):1038-42. PubMed ID: 327242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions.
    Speck B; Gluckman E; Haak HL; van Rood JJ
    Lancet; 1977 Dec; 2(8049):1145-8. PubMed ID: 73059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation using unrelated marrow donors.
    Fay JW; Collins RH; Piñeiro L
    Bone Marrow Transplant; 1993; 11 Suppl 1():81-2. PubMed ID: 8448557
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow transplantation from donors with aplastic anemia. A report from the ACS/NIH bone marrow transplant registry.
    JAMA; 1976 Sep; 236(10):1131-5. PubMed ID: 781333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allogeneic marrow transplantation in severe bone marrow aplasia. Factors determining the outcome in a series of 27 consecutive cases].
    Rozman C; Grañena A; Marín P; Hernández-Prieto M; Nomdedeu B; Montserrat E; Feliu E; Bladé J; Cervantes F; Vives Corrons JL
    Med Clin (Barc); 1985 Feb; 84(4):129-34. PubMed ID: 3884918
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prognosis of panmyelophthisis: Lynch's formula].
    Wehinger H; Lencer E
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):561-3. PubMed ID: 327301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.